FDA Clears Phase 2 Trial of Cannabis in PTSDThe FDA has given clearance for a phase 2 study to begin that will test smoked cannabis in veterans with post-traumatic stress disorder (PTSD). The study will enroll 320 veterans suffering from moderate-to-severe PTSD who have previously used cannabis. Investigations will assess the safety of real-world use of inhalation THC dried cannabis flower compared with placebo cannabis.
https://www.managedhealthcareexecutive.com/view/fda-clears-phase-2-trial-of-cannabis-in-ptsd